Mechanism for the paradoxical aciduria following alkali administration to prolonged-fasted patients
Bobby J. Stinebaugh(Instituto Conmemorativo Gorgas de Estudios de la Salud), Mitchell L. Halperin(St. Michael's Hospital), Marc B. Goldstein(McMaster University), Irving H. Fox(Takeda (United States)), Errol B. Marliss(McGill University Health Centre), Francis X. Schloeder(Instituto Conmemorativo Gorgas de Estudios de la Salud)
Cited by 12
Related Papers
Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis
|New England Journal of Medicine|2013|2.9k
Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
|New England Journal of Medicine|2013|2.7k
Effects of Vedolizumab Induction Therapy for Patients With Crohn’s Disease in Whom Tumor Necrosis Factor Antagonist Treatment Failed
|Gastroenterology|2014|714
Treatment of Ulcerative Colitis with a Humanized Antibody to the α <sub>4</sub> β <sub>7</sub> Integrin
|New England Journal of Medicine|2005|694